UniProt ID ▼ | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
A0A6J0ATE5 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A6J0AT59 | Cathepsin D |
|
2 | 0 |
|
A0A6J0ANA9 | Peptidyl-glycine alpha-amidating monooxygenase isoform X4 |
|
1 | 0 |
|
A0A6J0ALX7 | Peptidyl-glycine alpha-amidating monooxygenase isoform X7 |
|
1 | 0 |
|
A0A6J0AKD4 | P2X purinoceptor |
|
1 | 0 |
|
A0A6J0AFD8 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A6J0AFD3 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A6J0AF40 | Hyaluronidase |
|
1 | 0 |
|
A0A6J0AC99 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A6J0ABE2 | Hyaluronidase |
|
1 | 0 |
|
A0A6I9IRI4 | P2X purinoceptor |
|
1 | 0 |
|
A0A6I9IQS0 | Proto-oncogene tyrosine-protein kinase receptor Ret |
|
1 | 0 |
|
A0A6I9IQ23 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A6I9IM64 | Potassium channel subfamily K member |
|
1 | 0 |
|
A0A6I9ILH0 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A6I9IL25 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A6I9IK78 | Potassium channel subfamily K member 6 |
|
1 | 0 |
|
A0A6I9IK05 | P2X purinoceptor |
|
1 | 0 |
|
A0A6I9IJC4 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A6I9IHZ9 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A6I9IHT2 | Angiotensin-converting enzyme |
|
1 | 0 |
|
A0A6I9IGJ5 | Potassium channel subfamily K member |
|
1 | 0 |
|
A0A6I9IEE6 | Pannexin |
|
1 | 0 |
|
A0A6I9IE23 | Peptidyl-glycine alpha-amidating monooxygenase isoform X2 |
|
1 | 0 |
|
A0A6I9IDT7 | Peptidyl-glycine alpha-amidating monooxygenase isoform X5 |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024